President Obama’s executive order repealing restrictions on Embryonic Stem Cell research may have unintended consequences. Adult Stem Cell scientists and businesses are concerned that this action will divert attention and resources away from the promising Adult Stem Cell scientific advances.
Scientific progress made by companies such as STEMTech which owns the rights to the only patented product that is a 5:1 concentration of Aphenizomenon flos aqua (AFA) proven to enhance Adult Stem Cell release in a person’s own body may go relatively unnoticed if it were not for a dedicated team of independent distributors and WAHM work at home moms. Embryonic Stem Cell research however, is a multi-billion dollar industry with Wall Street, the media and now the U.S. government joining in to create visibility and mass funding which is providing an almost incalulable amount of free advertising that astute marketers are begining to realize the benefits of all this attention.